Enobia Pharma Corp — Form D/A
Enobia Pharma Corp of MONTREAL, A8, a company, filed a Form D amendment with the SEC on 2010-12-13. The offering totals $50.0M, of which $50.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-12-13
- Form: D/A
- Accession: 0001144204-10-065972
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $50.0M
- Amount sold: $50.0M
- Investors: 8
- Date of first sale: 2009-08-05
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-109028
Issuer
- Name: Enobia Pharma Corp
- CIK: 0001412621
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 2901 RACHEL ST., SUITE 23, MONTREAL, A8, H1W 4A4
- Phone: 514-596-2901
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| David Bonita | Director | New York, NY |
| Jonathan Silverstein | Director | Chicago, IL |
| Jeffrey Mack | Executive Officer | Virginia Beach, VA |
| Eric L Trachtenberg | Executive Officer | Watertown, MA |
| Richard Meadows | Director | Rancho Mirage, CA |
| Thomas Schuetz | Director | Cambridge, MA |
| Thomas L Schuetz | Director | MONTREAL, A8 |
| Luc L Mainville | Director | MONTREAL, A8 |
| Richard L Meadows | Director | MONTREAL, A8 |
| Frederic L Price | Director | MONTREAL, A8 |
| Jonathan L Silverstein | Director | MONTREAL, A8 |
| David L Bonita | Director | MONTREAL, A8 |
| Robert Heft | Director | MONTREAL, A8 |
| Robert Heft | Executive Officer | MONTREAL, A8 |
| Frederic Price | Director | Montreal, A8 |
| Luc Cournoyer | Executive Officer | Montreal, A8 |
| Luc Mainville | Director | Montreal, A8 |
Other filings by this issuer (3)
More